3 best performing ASX shares in the week of 30 May 2022
Marc Kennis, June 6, 2022
Best performing ASX shares
The three best performing ASX shares in the week of 30 May 2022 were Cardiex (ASX:CDX), up 39.7%, Carbonxt Group (ASX:CG1), up 32.9%, and Australian Dairy Nutritionals Group (ASX:AHF), up 30.2%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
1. Cardiex (ASX:CDX)
Industry: Healthcare
Cardiex Limited (ASX:CDX) is an ASX-listed public company with operations in medical technology, wearable devices and telehealth, providing digital and device-based solutions for large-scale population health disorders with significant market scale. Its current focus is cardiovascular disease (CVD) and heart health.
Market Cap: $49m
12 month high / low: $0.275 – $1.00
2. Carbonxt Group (ASX:CG1)
Industry: Chemicals
Carbonxt Group Limited (CG1) is involved in development and sale of specialised Activated Carbon (AC) products, including Powdered Activated Carbon (PAC) and AC pellets for the removal of pollutants and toxins in industrial processes. These products are used in industrial air purification, waste water treatment and other liquid and gas phase markets.
Market Cap: $37M
12 month high / low: $0.115 – $0.35
3. Australian Dairy Nutritionals Group (ASX:AHF)
Industry: Food & Beverage
Australian Dairy Nutritionals Group (AHF, previously named Australian Dairy Farms Group) is a vertically integrated Australian dairy group which owns quality dairy farms and a processing facility located in Southwestern Victoria, the Golden Triangle of Australia’s dairy industry. The Group is a trusted source of premium quality branded dairy products using milk sourced fresh from its farms.
Market Cap: $40m
12 month high / low: $0.043 – $0.105
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…
Trump’s Tariffs Are Back in the News—What’s the Impact on Global Supply Chains?
In recent months, the conversation around trade tariffs has re-emerged, with former President Donald Trump’s trade policies making headlines once…